BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 28, 2025
Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 14, 2016

View Archived Issues

China's Luye Pharma steps up M&A with $263M buyout of Acino

HONG KONG – In yet another of a growing list of acquisitions, Chinese drugmaker Luye Pharma Group Ltd. (2186.HK) has inked an agreement to acquire Swiss-based Acino Holdings AG's transdermal drug delivery systems (TDS) business. Read More

Sanofi China, Taiwan's JHL Biotech enter $236M partnership

HONG KONG – Sanofi SA entered a strategic alliance with Taiwan's JHL Biotech, Inc. which could provide a cash infusion and speed up the commercialization of JHL Biotech's biosimilar drugs in China. Read More

Hutchison's Epitinib passes BBB in lung cancer patients who have brain tumors

SHANGHAI – Shanghai-based Hutchison Medipharma Co. Ltd. presented phase I data for epitinib at the World Conference on Lung Cancer in Vienna showing that epitinib is a safe EGFR inhibitor with the ability to cross the blood-brain barrier (BBB). Read More

Eutilex raises $18M in largest life sci private financing for S. Korea

HONG KONG – Eutilex Co. Ltd. has raised $18 million in a series A financing, the largest private funding round for a startup in South Korea's life sciences sector. Read More

Boehringer, Chinese university to develop stem cell therapy for hearing loss

HONG KONG – Boehringer Ingelheim GmbH and China Southeast University Institute of Life Sciences are spearheading a research project to develop new treatments for hearing loss through regeneration of hair cells from inner ear stem cells. Read More

First dental vaccine moves toward clinical trials

HONG KONG — A world-first periodontitis vaccine that has been developed by Australian scientists, which could reduce or possibly even eliminate the need for surgery and antibiotics for the management of severe gum disease, has been validated by research published online Dec. 1, 2016, in npj Vaccines. Read More

Aussie firms could see faster approvals under proposed legislation

PERTH, Australia – Drug and device companies in Australia may soon be able to bring their products to market more quickly via a new priority review designation. Read More

Other news to note

Mitsubishi Tanabe Pharma Corp., of Osaka, Japan, presented data showing that patients with amyotrophic lateral sclerosis given edaravone intravenously in 10 to 14 day cycles for 48 weeks experienced significantly less functional loss as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented at the 27th International Symposium on ALS/MND (amyotrophic lateral sclerosis/motor neuron disease) in Dublin. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing